Redefining cancer photodynamic therapy with gold nanoparticles
Photochemistry and Photobiology · 2025-09 · 101 (5) · 1120-1138
DOI: 10.1111/php.14099 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Photochemistry and Photobiology, 2025-04. Verfasst von Zoey A Lockwood und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, College of Arts and Sciences, Case Western Reserve University, Cleveland, Ohio, USA. Hauptthemen laut MEDLINE: Gold, Photochemotherapy, Metal Nanoparticles, Neoplasms. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 145 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Case Western Reserve University Expanding Horizon Initiative.
Abstract (Originalsprache)
Despite advancements made in treatment options, cancer continues to be one of the leading causes of death worldwide. Photodynamic therapy (PDT) has gained attention as a minimally invasive and highly selective treatment option for cancer. However, challenges due to the hydrophobicity of photosensitizers and their poor tumor selectivity have limited their use in cancer therapy. Recent developments in nanotechnology, particularly the use of gold nanoparticles (AuNPs), help overcome these challenges. AuNPs provide a stable and biocompatible platform to deliver photosensitizers, improving their solubility, stability, and ability to target tumors while reducing side effects. Functionalized AuNPs take advantage of mechanisms like the enhanced permeability and retention (EPR) effect and active targeting, improving reactive oxygen species (ROS) production and overall therapeutic efficacy. This review explores innovations in AuNP‐based PDT systems, including ligand‐functionalized nanoparticles, bioresponsive coatings, and theranostic approaches that combine imaging with therapy. By delving into important aspects of synthesis, characterization, and functionalization, we show how AuNPs improve the delivery and performance of photosensitizers. For instance, systems functionalized with prostate‐specific membrane antigen (PSMA) have shown increased therapeutic precision and efficacy in vivo. These advancements are paving the way for more targeted and safer cancer treatments, establishing AuNP‐based PDT as a promising approach for developing highly effective oncological therapies with greater precision and fewer side effects.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, College of Arts and Sciences, Case Western Reserve University, Cleveland, Ohio, USA.
- Department of Radiology, School of Medicine, Case Western Reserve University, Cleveland, Ohio, USA.
ORCID-Profile: Zoey A Lockwood
Förderung
- Case Western Reserve University Expanding Horizon Initiative
Zitieren
APA
Lockwood, Z. A., Jirousek, M. R., Basilion, J. P., & Burda, C. (2025). Redefining cancer photodynamic therapy with gold nanoparticles. Photochemistry and Photobiology, 101(5), 1120-1138. https://doi.org/10.1111/php.14099
Vancouver
Lockwood ZA, Jirousek MR, Basilion JP, Burda C. Redefining cancer photodynamic therapy with gold nanoparticles. Photochemistry and Photobiology. 2025;101(5):1120-1138. doi:10.1111/php.14099
BibTeX
@article{Lockwood2025,
author = {Lockwood, Zoey A and Jirousek, Michael R and Basilion, James P and Burda, Clemens},
title = {Redefining cancer photodynamic therapy with gold nanoparticles},
journal = {Photochemistry and Photobiology},
year = {2025},
volume = {101},
number = {5},
pages = {1120--1138},
doi = {10.1111/php.14099}
}
EUVIMED